PTIX
Protagenic Therapeutics, Inc.\new
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Revenue
$0
NaN%
Net Income
$1.4M
↑ 138.1%
Operating Income
$-4503710
↓ 73.6%
EPS (Diluted)
$0.59
↑ 188.1%
Total Assets
$3.7M
↑ 3997.3%
Total Liabilities
$1.0M
↓ 79.5%
Shareholders' Equity
$2.6M
↑ 152.9%
Cash & Equivalents
$671091.00
↓ 16.0%

Recent SEC Filings

Form Type Filed Date Link
NT 10-Q 8/14/2026 View on SEC
10-K 8/14/2026 View on SEC
4 8/12/2026 View on SEC
4 8/10/2026 View on SEC
4 8/6/2026 View on SEC
4 8/3/2026 View on SEC
NT 10-K 6/30/2026 View on SEC
8-K 4/7/2026 View on SEC
10-Q 3/9/2026 View on SEC
8-K 3/3/2026 View on SEC

Company Information

Field Value
Ticker PTIX
Company Name Protagenic Therapeutics, Inc.\new
CIK 1022899
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 0331
State of Incorporation DE
Phone (212) 994-8200